Health Care & Life Sciences » Pharmaceuticals | Nectar Lifesciences Ltd.

Nectar Lifesciences Ltd. | Cash Flow

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
782
848
647
674
-
Depreciation, Depletion & Amortization
842
766
574
623
-
Other Funds
4
1
-
-
-
Funds from Operations
1,448
1,580
1,127
1,085
1,166
Changes in Working Capital
163
1,193
615
203
-
Net Operating Cash Flow
1,285
387
511
881
-
Capital Expenditures
1,016
805
824
534
-
Sale of Fixed Assets & Businesses
-
11
1
284
-
Purchase/Sale of Investments
-
-
2
1
-
Net Investing Cash Flow
1,016
794
825
249
-
Cash Dividends Paid - Total
22
22
27
27
-
Issuance/Reduction of Debt, Net
213
663
373
840
-
Net Financing Cash Flow
232
641
346
867
-
Net Change in Cash
37
234
33
235
-
Free Cash Flow
269
418
269
434
-
Other Sources
-
-
-
-
-
Other Uses
1
-
-
-
-

About Nectar Lifesciences

View Profile
Address
SCO 38-39, Madhya Marg
Chandigarh Uttarakhand 160009
India
Employees -
Website http://www.neclife.com
Updated 09/14/2018
Nectar Lifesciences Ltd. is a pharmaceutical company, which engages in manufacturing and delivering of pharmaceutical products. Its business activities include contract research and manufacturing; API and intermediates; formulations; diagnostics; empty hard gelatin capsules; and menthol. The company was founded by Sanjiv Goyal on June 27, 1995 and is headquartered in Chandigarh, India.